RPID has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RPID has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Rapid Micro Biosystems's Cash per Share for the quarter that ended in Mar. 2024 was $1.86.
The historical data trend for Rapid Micro Biosystems's Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rapid Micro Biosystems Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Cash per Share | 0.46 | 1.42 | 4.67 | 2.58 | 2.17 |
Rapid Micro Biosystems Quarterly Data | ||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Cash per Share | Get a 7-Day Free Trial | 2.36 | 2.51 | 2.11 | 2.17 | 1.86 |
This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.
Rapid Micro Biosystems's Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as:
Cash per Share | = | Cash, Cash Equivalents, Marketable Securities | / | Shares Outstanding (EOP) |
= | 92.053 | / | 42.41 | |
= | 2.17 |
Rapid Micro Biosystems's Cash per Share for the quarter that ended in Mar. 2024 is calculated as:
Cash per Share | = | Cash, Cash Equivalents, Marketable Securities | / | Shares Outstanding (EOP) |
= | 79.536 | / | 42.79 | |
= | 1.86 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rapid Micro Biosystems (NAS:RPID) Cash per Share Explanation
Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.
Thank you for viewing the detailed overview of Rapid Micro Biosystems's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Sean M Wirtjes | officer: Chief Financial Officer | C/O VARIAN, INC., 3120 HANSEN WAY, M/S D-083, PALO ALTO CA 94304-1030 |
Spignesi Robert G. Jr. | director, officer: President and CEO | C/O RAPID MICRO BIOSYSTEMS, INC., 1001 PAWTUCKET BOULEVARD WEST, SUITE 280, LOWELL MA 01854 |
Kirk Malloy | director | 5200 ILLUMINA WAY, SAN DIEGO CA 92122 |
Kennedy Lewis Capital Partners Master Fund Ii Lp | 10 percent owner | 111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120 |
Klm Gp Llc | 10 percent owner | 80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004 |
Kennedy Lewis Capital Partners Master Fund Iii Lp | 10 percent owner | 111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120 |
Kennedy Lewis Gp Ii Llc | 10 percent owner | 111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120 |
Kennedy Lewis Gp Iii Llc | 10 percent owner | 111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120 |
Kennedy Lewis Investment Holdings Ii Llc | 10 percent owner | 111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120 |
Kennedy Lewis Investment Management Llc | 10 percent owner | 80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004 |
Kennedy Lewis Management Lp | 10 percent owner | 225 LIBERTY STREET, SUITE 4210, NEW YORK NY 10281 |
David Chene | 10 percent owner | 80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004 |
Darren Richman | 10 percent owner | 80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004 |
Inese Lowenstein | director | C/O RAPID MICRO BIOSYSTEMS INC, 1001 PAWTUCKET BOULEVARD WEST, SUITE 280, LOWELL MA 01854 |
Richard A Keys | officer: CHIEF COMMERCIAL OFFICER | C/O RAPID MICRO BIOSYSTEMS INC, 1001 PAWTUCKET BOULEVARD, SUITE 280, LOWELL MA 01854 |
From GuruFocus
By Value_Insider Value_Insider • 11-02-2022
By sperokesalga sperokesalga • 02-28-2023
By sperokesalga sperokesalga • 04-13-2023
By GlobeNewswire GlobeNewswire • 05-09-2023
By PRNewswire PRNewswire • 07-10-2022
By PurpleRose PurpleRose • 08-09-2022
By Marketwired • 08-04-2023
By Marketwired • 07-20-2023
By PurpleRose PurpleRose • 08-12-2022
By sperokesalga sperokesalga • 02-16-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.